Vertex Pharmaceuticals Incorporated (BMV:VRTX)

Mexico flag Mexico · Delayed Price · Currency is MXN
7,731.22
-332.28 (-4.12%)
At close: Jan 15, 2026
-5.13%
Market Cap1.97T
Revenue (ttm)215.03B
Net Income (ttm)67.41B
Shares Outn/a
EPS (ttm)260.87
PE Ratio29.27
Forward PE21.70
Dividendn/a
Ex-Dividend Daten/a
Volume355
Average Volume311
Open7,731.22
Previous Close8,063.50
Day's Range7,731.22 - 7,731.22
52-Week Range6,800.00 - 10,318.00
Beta0.31
RSI45.52
Earnings DateFeb 12, 2026

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 6,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements